Smart Finance HK Stock Repurchase Statistics | August 23rd

Hong Kong stock repurchase statistics | August 23rd

Zhitong FinanceAug 22 21:10 ET

haohai biotec (06826.HK) spent 1.6442 million Hong Kong dollars on repurchasing 0.0564 million shares on August 22nd.

gelonhui August 22nd | haohai biotec (06826.HK) announced that on August 22, 2024, it spent 1.6442 million Hong Kong dollars to repurchase 0.0564 million shares, with a repurchase price of 28.95-29.4 Hong Kong dollars per share.

Gelonghui FinanceAug 22 05:38 ET

haohai biotec (06826.HK) spent 1.5375 million Hong Kong dollars on August 21 to repurchase 0.0525 million shares.

haohai biotec (06826.HK) announced on August 21st that it will spend 1.5375 million Hong Kong dollars to repurchase 0.0525 million shares on August 21, 2024, with a repurchase price of HKD 29-29.5 per share.

Gelonghui FinanceAug 21 05:30 ET

Intelligent Hong Kong Stocks Repurchase Statistics | August 21

Statistics on Hong Kong stock repurchases | August 21

Zhitong FinanceAug 20 21:10 ET

[Brokerage Focus] Northeast Securities maintains a 'buy' rating for haohai biotec (06826), expecting an increase in the proportion of high-end products and revenue to return to the growth range.

Jingu Finance | Northeast Securities released a research report, indicating that Haohai Biotec (06826) achieved a revenue of CNY 1.397 billion in 24H1, an increase of 7.00% YoY, and a net income attributable to owners of CNY 0.235 billion, an increase of 14.64% YoY. In Q2, the company achieved a revenue of CNY 0.751 billion in a single quarter, an increase of 8.16% YoY, and a net income attributable to owners of CNY 0.138 billion, an increase of 11.03% YoY. It is planned to distribute a cash dividend of CNY 4 per 10 shares (including tax). The bank continued to point out that the company's hyaluronic acid products continued to exceed expectations, and Huiwei, Jiaolan, and Haimei promoted high growth of hyaluronic acid. The fourth-generation hyaluronic acid "Haimei Yuebai" was successfully approved in July 2024, verifying once again.

金吾財訊Aug 20 03:32 ET

Shanghai Haohai Biological Technology H1 Profit Up 15%; Shares Rise 4%

MT NewswiresAug 19 01:23 ET